Evaluates oligodendrocyte ensheathment in human cells, suggesting a new model for neurological research.
Oligodendrocytes are glial cells responsible for myelination in the central nervous system, and their dysfunction underlies various neurological disorders. However, existing human oligodendrocyte models are limited by low efficiency and insufficient standardization. Here, we developed a well-defined system for differentiating human oligodendrocytes from induced pluripotent stem cells using transient transcription factor expression. To recapitulate key structural aspects of oligodendrocyte-axon interactions, we cultured oligodendrocytes on nanofibers mimicking axonal topology. On this platform, ultrastructural, live-imaging, and transcriptomic analyses demonstrated dynamic oligodendrocyte-nanofiber interactions and ensheathment-like wrapping. This process was accompanied by aligned CLDN11 expression along nanofibers, providing a quantifiable structural readout without overt maturation. To validate the utility of the platform, we quantified the effects of white matter toxins and pro-ensheathment lipids. Our findings establish a robust system for evaluating oligodendrocyte ensheathment modulators, particularly those affecting cytoskeletal organization and initial sheath formation, and for investigating the pathophysiology of human oligodendrocyte-related disorders.
No takes yet. Share an insight, caveat, or question.
Morita et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: